Improving breast and cervical cancer screening in Kenya
Official title: Enhanced BReast and cErvical cAncer screening in Kenya THROUGH implementation science research and training (The BREAKTHROUGH Center)
Funded at Emory University · NIH-11403676 · Data updated 2026-11-12
This project partners with Kenyan hospitals, clinics, and communities to make it easier for people to get breast and cervical cancer screening and timely follow-up care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $560,380 |
| NIH project number | 3U54CA284036-03S1 |
| Project ID | NIH-11403676 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women in Kenya who are eligible for breast or cervical cancer screening—including those living with HIV—and people who can attend participating clinics are the main candidates.
✕Less likely to help
People who live outside Kenya, men who are not at risk for these cancers, or patients already under advanced cancer treatment may not benefit directly from this screening-focused work.
What this research studies
From my perspective as someone in Kenya, the BREAKTHROUGH Center brings together hospitals, universities, and community groups to close gaps in cancer screening and treatment. They will run two linked research projects plus training programs, and use an administrative and engagement core to work with local clinics and government partners. The work focuses on practical changes like staff training, outreach, and better systems for screening and follow-up at participating sites. The aim is to make proven screening methods part of routine care so cancers are found earlier and treated sooner.
Why it matters
Potential benefit: If successful, more people could be screened earlier, catch cancers at treatable stages, and get faster access to care.
How similar studies have gone: Screening programs have lowered cancer deaths in well-resourced settings, but sustainably delivering and scaling these programs in Kenya is less tested and is what this center aims to address.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Chung, Michael Hoonbae — Emory University
- Study coordinator: Chung, Michael Hoonbae
Related research
Other NIH-funded projects on the same topics.
-
Enhanced breast and cervical cancer screening in Kenya through implementation science and training
A multi-institution effort to boost breast and cervical cancer screening, follow-up, and treatment in Kenya using hands-on implementation science and training.
-
Enhanced breast and cervical cancer screening in Kenya through implementation science and training
A Breakthrough center project in Kenya aims to improve breast and cervical cancer screening, follow-up, and treatment through real-world implementation approaches and training.
-
Improving breast and cervical cancer screening in Kenya
This study is working to make it easier for women in Kenya to get screened and treated for breast and cervical cancers by training healthcare providers and improving how screening and treatment are connected, so that more women can catch these cancers early and get the help they need.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
HOPE-inG: Increasing cervical cancer screening for women with HIV in Ghana
A study tests a home-based HPV self-sampling approach plus a tailored communication plan to help women living with HIV in Ghana get screened more often for cervical cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.